113
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Arginine Biosynthesis Pathway Found to Play a Key Role in the Neuroprotective Effect of Liu-Wei-Luo-Bi (LWLB) Granules in Diabetic db/db Mice with Peripheral Neuropathy Using an Untargeted Metabolomics Strategy

, , , , , , , , , & show all
Pages 4065-4080 | Received 10 Jul 2023, Accepted 01 Nov 2023, Published online: 10 Dec 2023

References

  • Stino AM, Smith AG. Peripheral neuropathy in prediabetes and the metabolic syndrome. J Diabetes Investig. 2017;8(5):646–655. doi:10.1111/jdi.12650
  • Selvarajah D, Kar D, Khunti K, et al. Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention. Lancet Diabetes Endocrinol. 2019;7(12):938–948. doi:10.1016/S2213-8587(19)30081-6
  • Iqbal Z, Azmi S, Yadav R, et al. Diabetic peripheral neuropathy: epidemiology, diagnosis, and pharmacotherapy. Clin Ther. 2018;40(6):828–849. doi:10.1016/j.clinthera.2018.04.001
  • Faselis C, Katsimardou A, Imprialos K, et al. Microvascular complications of type 2 diabetes mellitus. Curr Vasc Pharmacol. 2020;18(2):117–124. doi:10.2174/1570161117666190502103733
  • Vinik AI, Nevoret ML, Casellini C, et al. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747–787. doi:10.1016/j.ecl.2013.06.001
  • Calcutt NA. Diabetic neuropathy and neuropathic pain: a (con)fusion of pathogenic mechanisms. Pain. 2020;161(Suppl 1):S65–S86. doi:10.1097/j.pain.0000000000001922
  • Javed S, Alam U, Malik RA. Burning through the pain: treatments for diabetic neuropathy. Diabetes Obes Metab. 2015;17(12):1115–1125. doi:10.1111/dom.12535
  • Sakai D, Nakai T, Hiraishi S, et al. Upregulation of glycosaminoglycan synthesis by Neurotropin in nucleus pulposus cells via stimulation of chondroitin sulfate N-acetylgalactosaminyltransferase 1: a new approach to attenuation of intervertebral disc degeneration. PLoS One. 2018;13(8):e0202640. doi:10.1371/journal.pone.0202640
  • Jensen TS, Backonja MM, Hernández Jiménez S, et al. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res. 2006;3(2):108–119. doi:10.3132/dvdr.2006.013
  • Sloan G, Shillo P, Selvarajah D, et al. A new look at painful diabetic neuropathy. Diabetes Res Clin Pract. 2018;144:177–191. doi:10.1016/j.diabres.2018.08.020
  • Tang HY, Jiang AJ, Ma JL, et al. Understanding the signaling pathways related to the mechanism and treatment of diabetic peripheral neuropathy. Endocrinology. 2019;160(9):2119–2127. doi:10.1210/en.2019-00311
  • Xin X, Zou H, Zheng N, et al. Metabonomic strategy to the evaluation of Chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats. Evid Based Complement Alternat Med. 2013;2013:718305. doi:10.1155/2013/718305
  • Durán AM, Beeson WL, Firek A, et al. Dietary Omega-3 polyunsaturated fatty-acid supplementation upregulates protective cellular pathways in patients with type 2 diabetes exhibiting improvement in painful diabetic neuropathy. Nutrients. 2022;14(4):761. doi:10.3390/nu14040761
  • Rondón LJ, Farges MC, Davin N, et al. L-Arginine supplementation prevents allodynia and hyperalgesia in painful diabetic neuropathic rats by normalizing plasma nitric oxide concentration and increasing plasma agmatine concentration. Eur J Nutr. 2018;57(7):2353–2363. doi:10.1007/s00394-017-1508-x
  • Schrimpe-Rutledge AC, Codreanu SG, Sherrod SD, et al. Untargeted metabolomics strategies-challenges and emerging directions. J Am Soc Mass Spectrom. 2016;27(12):1897–1905. doi:10.1007/s13361-016-1469-y
  • Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol. 2012;13(4):263–269. doi:10.1038/nrm3314
  • Ussher JR, Elmariah S, Gerszten RE, et al. The emerging role of metabolomics in the diagnosis and prognosis of cardiovascular disease. J Am Coll Cardiol. 2016;68(25):2850–2870. doi:10.1016/j.jacc.2016.09.972
  • Zhang A, Sun H, Wang Z, et al. Metabolomics: towards understanding traditional Chinese medicine. Planta Med. 2010;76(17):2026–2035. doi:10.1055/s-0030-1250542
  • Wu GS, Li HK, Zhang WD. Metabolomics and its application in the treatment of coronary heart disease with traditional Chinese medicine. Chin J Nat Med. 2019;17(5):321–330. doi:10.1016/S1875-5364(19)30037-8
  • Yu-te Z, Qiong S, Yu-ting Y, et al. Trilobatin ameliorates HFD/STZ-induced glycolipid metabolism disorders through AMPK-mediated pathways. J Funct Foods. 2023;103:105478.
  • Yang M, Lao L. Emerging applications of metabolomics in Traditional Chinese Medicine treating hypertension: biomarkers, pathways and more. Front Pharmacol. 2019;10:158. doi:10.3389/fphar.2019.00158
  • Fu Y, Zou T, Shen X, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm. 2020;2(1):27–59. doi:10.1002/mco2.27
  • Wang M, Chen L, Liu D, et al. Metabolomics highlights pharmacological bioactivity and biochemical mechanism of Traditional Chinese Medicine. Chem Biol Interact. 2017;273:133–141. doi:10.1016/j.cbi.2017.06.011
  • Li Y, Yao W, Gao Y. Effects of Tang Luo Ning on diabetic peripheral neuropathy in rats revealed by LC-MS metabolomics approach. Biomed Chromatogr. 2022;36(7):e5374. doi:10.1002/bmc.5374
  • Ren JL, Zhang AH, Kong L, et al. Analytical strategies for the discovery and validation of quality-markers of traditional Chinese medicine. Phytomedicine. 2020;67:153165. doi:10.1016/j.phymed.2019.153165
  • He Y, Zhang H, Yang Y, et al. Using metabolomics in diabetes management with Traditional Chinese Medicine: a review. Am J Chin Med. 2021;49(8):1813–1837. doi:10.1142/S0192415X21500865
  • Ma X, Chi Y-H, Niu M, et al. Metabolomics coupled with multivariate data and pathway analysis on potential biomarkers in cholestasis and intervention effect of Paeonia lactiflora pall. Front Pharmacol. 2016;7:14. doi:10.3389/fphar.2016.00014
  • Jobgen WS, Fried SK, Fu WJ, et al. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17(9):571–588. doi:10.1016/j.jnutbio.2005.12.001
  • Todorovic SM. Painful diabetic neuropathy: prevention or suppression? Int Rev Neurobiol. 2016;127:211–225.
  • Raghavan SA, Dikshit M. Vascular regulation by the L-arginine metabolites, nitric oxide and agmatine. Pharmacol Res. 2004;49(5):397–414. doi:10.1016/j.phrs.2003.10.008
  • Reyes AA, Karl IE, Klahr S. Role of arginine in health and in renal disease. Am J Physiol. 1994;267(3 Pt 2):F331–F346. doi:10.1152/ajprenal.1994.267.3.F331
  • Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J. 1998;336(Pt 1):1–17. doi:10.1042/bj3360001
  • Flynn NE, Meininger CJ, Haynes TE, et al. The metabolic basis of arginine nutrition and pharmacotherapy. Biomed Pharmacother. 2002;56(9):427–438. doi:10.1016/S0753-3322(02)00273-1
  • Wijnands KA, Castermans TM, Hommen MP, et al. Arginine and citrulline and the immune response in sepsis. Nutrients. 2015;7(3):1426–1463. doi:10.3390/nu7031426
  • Do KQ, Benz B, Grima G, et al. Nitric oxide precursor arginine and S-nitrosoglutathione in synaptic and glial function. Neurochem Int. 1996;29(3):213–224. doi:10.1016/0197-0186(96)00002-2
  • Ma X, Ruan G, Wang Y, et al. Two single-nucleotide polymorphisms with linkage disequilibrium in the human programmed cell death 5 gene 5’ regulatory region affect promoter activity and the susceptibility of chronic myelogenous leukemia in Chinese population. Clin Cancer Res. 2005;11(24 Pt 1):8592–8599. doi:10.1158/1078-0432.CCR-05-0039
  • Sun Y, Kong L, Zhang AH, et al. A hypothesis from metabolomics analysis of diabetic retinopathy: arginine-creatine metabolic pathway may be a new treatment strategy for diabetic retinopathy. Front Endocrinol. 2022;13:858012. doi:10.3389/fendo.2022.858012
  • Nishio A, Rehermann B. Virus-induced interferon regulates the urea cycle. Immunity. 2019;51(6):975–977. doi:10.1016/j.immuni.2019.11.012
  • Shekunova EV, Kashkin VA, Muzhikyan AА, et al. Therapeutic efficacy of arginine-rich exenatide on diabetic neuropathy in rats. Eur J Pharmacol. 2020;866:172835. doi:10.1016/j.ejphar.2019.172835
  • Tejero J, Hunt AP, Santolini J, et al. Mechanism and regulation of ferrous heme-nitric oxide (NO) oxidation in NO synthases. J Biol Chem. 2019;294(19):7904–7916. doi:10.1074/jbc.RA119.007810
  • Thomsen K, Rubin I, Lauritzen M. NO- and non-NO-, non-prostanoid-dependent vasodilatation in rat sciatic nerve during maturation and developing experimental diabetic neuropathy. J Physiol. 2002;543(Pt 3):977–993. doi:10.1113/jphysiol.2002.023564